Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LINC00310 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101928370 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LMO4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC285902 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPAT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506089 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLCS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WBP2NL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBARP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XIST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAPGEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCMDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GMEB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on